Why Martha Stewart Could Give Canopy Growth (TSX:WEED) a Big Edge in the Edibles Market

Canopy Growth Corp (TSX:WEED)(NYSE:CGC) still has a lot of potential growth in the Canadian market with the launch of edible products right around the corner.

| More on:
Female scientist in a hemp field checking plants and flowers, alternative herbal medicine concept

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn moresdf

Recently, we learned that the edibles market for cannabis would be ready to go by mid-December. Many companies have been ramping up and getting ready for the launch, including Hexo Corp, which said that it will have cannabis-infused beverages ready to go on day one. It’s likely that Canopy Growth Corp (TSX:WEED)(NYSE:CGC), which has partnered with beer maker Constellation Brands, will also have some products lined up.

When it comes to the broader edibles segment, however, Canopy Growth could have a big advantage over its rivals by having a name like Martha Stewart behind its products. With so many products and options for consumers to choose from, having a way to differentiate and stand out from the rest will be key. And by having Stewart vouch for them and claim to use them will go a long way to adding credibility to the products, especially with her fans.

At the World Cannabis Congress, she recently stated, “I’ve been experimenting little bit with some of the good products that are available now, I find them very useful and really good for your skin, and I think the anti-inflammatory qualities of some of them are very good.”

With Stewart working on various projects including animal products and cosmetics, Canopy Growth will be able to develop a wide array of products that she will have had a hand in. The biggest opportunity could be in food products, where she says. “Martha Stewart Living has 30,000 or 35,000 original recipes, and those can be adapted with cannabis or CBD or whatever we’re going to use.”

The sky’s the limit as far as how Canopy Growth can benefit as a result of having Stewart on board, which should get investors excited for the company’s potential growth once the edibles market launches. What’s even more exciting is that Stewart’s name likely has much more of an impact south of the border, where Canopy Growth can’t yet sell its edible products, with the one exception being hemp-based products.

The federal legalization of marijuana in the U.S., whenever it happens, will open the floodgates, giving the company access to a massive new market.

In Canada, it may take some time for the edibles market to realize its potential, as the rollout is likely going to take some time as supply and other issues may constrain the market. However, it can offer a good testing ground for cannabis producers to see what works and what doesn’t in preparation for what will be a much bigger launch when the U.S. market becomes available.

Bottom line

Canopy Growth has done a phenomenal job of growing and developing its brand, making it the unquestioned market leader up to this point. It has brought in big names to help grow its company, and Martha Stewart could prove to be a very significant one in the edibles segment. While the stock may still be an expensive one today, with all the growth potential that the company has, it could still prove to be a good buy today.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor David Jagielski has no position in any of the stocks mentioned.

More on Cannabis Stocks

Cannabis smoke
Cannabis Stocks

Canopy Growth Stock: Is Now a Good Time to Invest?

The road ahead is highly uncertain for Canopy Growth, as the stock is plagued with losses and seemingly unsurmountable industry…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

TLRY Stock: Should You Invest Now?

TLRY is a Canadian cannabis stock which is trading 91% below record highs. Let's see if you should own TLRY…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

Is Tilray Stock a Buy in February 2023?

Despite the volatile cannabis sector, Tilray could be a superb buy for long-term investors.

Read more »

Young woman sat at laptop by a window
Cannabis Stocks

Is SNDL Stock a Buy in February 2023?

SNDL is a beaten-down cannabis stock. While its revenue growth is exceptional, a weak balance sheet has driven stock prices…

Read more »

A cannabis plant grows.
Cannabis Stocks

TLRY Stock: Here’s What’s Coming in 2023

Tilray Inc. (TSX:TLRY) is geared up for big growth this decade and looks like one of the top cannabis stocks…

Read more »

A person holds a small glass jar of marijuana.
Cannabis Stocks

Canopy Growth Stock: Here’s What’s Coming in 2023

Canopy Growth stock has made a lot of new moves in the last few months, but where is the company…

Read more »

A cannabis plant grows.
Cannabis Stocks

Better Cannabis Buy: Canopy Growth Stock or Tilray?

Only two TSX weed stocks can deliver substantial returns in the highly anticipated growth of the global cannabis market.

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

Is Tilray Stock a Buy in January 2023?

Tilray stock has lost 50% of its value in the last 12 months, in line with its peers.

Read more »